Nivolumab maintains function and reduces symptoms in treatment of relapsed metastatic head and neck cancer, according to results from the CheckMate 141 trial.

Source: Nivolumab maintains function, reduc...relapsed metastatic head and neck cancer


David Cottle

UBB Owner & Administrator